Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:11 AM
Ignite Modification Date:
2025-12-25 @ 4:11 AM
NCT ID:
NCT05080920
Eligibility Criteria:
Inclusion Criteria:
* Patients with a solid cancer under active Anticancer Treatment (including Chemotherapy, Immunotherapy, Hormone Therapy, Targeted Therapy)
* Informed consent signature
Exclusion Criteria:
* Allergies to fish
* Vitamin, Antioxidants consumers and who would no accept to stop taking them 1 week before and during the study
* Disphagia
* Bilirrubin higher than 1.5 Upper Normal Limit (UNL)/ Creatinin \> 1.5 UNL
* Severe organic dysfunction
* Cardiac dysfunction
* Cholangitis/ Biliary tract obstruction
* Immunodeficiency or Immflamatory disease (HIV, Inflammatory Bowel Disease, Collagenosis)
* Dementia or Psychiatric severe disease
* Pregnancy or Breastfeeding
* Previous diseases that interfere lipid carrier absorption
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT05080920
Study Brief:
Protocol Section:
NCT05080920